东营怎么治癫痫(江苏羊角风发病怎么办) (今日更新中)

Bahamas woman explains her experience with Hurricane Dorian's feederbandsWe talked to Rosie Lopez in North Eleuthera, Bahamas by phone as Hurricane Dorian's powerful feeder bands passed her home. She says she didn't experience a direct hit but she did endure Tropical Storm force winds. 301

PENSACOLA, Fla. – The City of Pensacola has fallen victim to a cyber attack, according to Mayor Grover Robinson. Robinson made the announcement at a weekly press conference Monday, saying almost all computer communication systems in City Hall are down, 266

A Cleveland police spokesperson confirmed that two Remington shotguns were stolen from two police cruisers that were parked near the city's Justice Center and set on fire during the riot that broke out during the police violence protest last month.During the May 30 riot, News 5 cameras caught people in the streets vandalizing police cars.One of the cruisers was tagged with the word "pigs" on the trunk. The vehicle could later be seen fully engulfed in flames.As of now, no arrests have been made. RELATED: VIDEO: Protesters and police clash in Cleveland during George Floyd demonstration This story was written by Courtney Shaw for WEWS. 664

INDIANAPOLIS — The U.S. Food and Drug Administration on Monday granted emergency use authorization to Eli Lilly and Company's experimental COVID-19 antibody treatment bamlanivimab.According to a statement from the company, the drug is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test who are at high risk for progressing to severe COVID-19 and/or hospitalization. Lilly said in a statement the drug should be administered as soon as possible after a positive COVID-19 test and within 10 days of symptom onset. The authorization allows for the distribution and emergency use of bamlanivimab, which is administered via a single intravenous infusion."This emergency authorization allows us to make bamlanivimab available as a COVID-19 treatment for recently diagnosed, high-risk patients — adding a valuable tool for doctors fighting the now-increasing burden of this global pandemic," David A. Ricks, Lilly's chairman and CEO, said. "The rapid development and availability of bamlanivimab could not have been achieved without the relentless work of our Lilly team, collaboration across the industry and the urgent work being done by the government to ensure appropriate allocation to patients who need it the most."The emergency use authorization is based on data from BLAZE-1, a randomized, double-blind, placebo-controlled Phase 2 study in patients with recently diagnosed mild to moderate COVID-19 in the outpatient setting. Patients treated with the drug showed reduced viral load and rates of symptoms and hospitalization, Lilly said in the statement. Infusion reactions and other allergic hypersensitivity events have been reported, Lilly said. The emergency use authorization includes a warning for hypersensitivity including anaphylaxis and infusion-related reactions.Lilly said the drug is not authorized for use in patients who are hospitalized due to COVID-19 or who require oxygen therapy due to COVID-19 or who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity."The BLAZE-1 data show bamlanivimab, when given early in the disease course, may help patients clear the virus and reduce COVID-related hospitalizations, supporting our belief that neutralizing antibodies can be an important therapeutic option for patients fighting this virus," Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific officer and president of Lilly Research Laboratories, said. "We're proud of the speed with which we have been able to bring patients this therapy specifically designed to treat COVID-19. We thank those who have contributed to this medical advancement, particularly the clinical trial investigators and participants around the country." This article was written by Bob Blake for WRTV. 2906

CA?ON CITY, Colo. – Thousands have come through the gates of the Colorado Territorial Correctional Facility. But what happens when they walk out? The prison has dozens of programs meant to help the inmates become valued members of society. One program – involving dogs – is called the Prison Trained K-9 Companion Program. Lawrence Trujillo and Zachery Montoya are master dog trainers. They've have been training dogs at the corrections center for five years. “We are with these dogs seven days a week, 24 hours a day,” Trujillo said. They teach the dogs how to follow commands, and how to be on their best behavior. It’s a very coveted job. “Some of these guys haven’t seen a dog in 20 years,” Montoya said. However, getting into the program isn’t easy. “In order to be considered they actually have to apply for the job. They have to meet certain criteria – they have to have a GED – because we’re required them to read information and process it. And they have to be on their best behavior documented for at least six months," K-9 supervisor Michele Wayland said. According to Wayland, it takes about a year to achieve a master handler certification. “We get a dog buddy, and we learn from a master trainer. We go through about 14 months of book work, we have tests in their monthly – hands on tests with the dogs as we progress as trainers – and we have to pass each one of those tests to become a master trainer,” Trujillo said. The guys say they gain more than just life skills. They're also helping families who haven’t been able to effectively train their dogs. “Coming to prison is not so fun, but being able to give something back is very rewarding,” Montoya said. Since the program was created in 2002, inmates have trained nearly 13,000 dogs. A majority of them come from private families who help fund the program through boarding and training fees. “There is no taxpayer dollar supporting this program, so we have to float our own boat,” Wayland said. The program has seen a lot of success the past couple decades. Wayland says Colorado was one of the first, if not the first state to start K-9 training at prisons. Now, they're all across the country. “There actually is a K-9 program in prisons in every state of the union,” Wayland said. The positive results of the program can be seen in the inmates who are hired. “I didn’t have a lot of skills before I came to prison, so this is something I could definitely I could take with me and do out there. There’s been many guys who have left and have been successful doing this one the streets,” Montoya said. Whether working at a shelter, a kennel, or starting their own training business, both Montoya and Trujillo say they’d love to continue working with dogs once they get out of prison. It's something that wouldn’t be possible without the help of dog owners“We would just like – probably as a team – to thank them for their support and appreciate the trust they have in us,” Trujillo said. 2973

来源：资阳报